The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

Identification of the transmitted/founder virus makes possible, for the first time, a genome-wide analysis of host immune responses against the infecting HIV-1 proteome. A complete dissection was made of the primary HIV-1-specific T cell response induced in three acutely infected patients. Cellular...

Bibliografski detalji
Glavni autori:	Goonetilleke, N, Liu, M, Salazar-Gonzalez, J, Ferrari, G, Giorgi, E, Ganusov, V, Keele, B, Learn, G, Turnbull, E, Salazar, MG, Weinhold, K, Moore, S, Letvin, N, Haynes, B, Cohen, MS, Hraber, P, Bhattacharya, T, Borrow, P, Perelson, A, Hahn, B, Shaw, G, Korber, B, Mcmichael, A
Format:	Journal article
Jezik:	English
Izdano:	2009

Slični predmeti

Quantifying factors determining the rate of CTL escape and reversion during acute and chronic phases of HIV infection
od: Ganusov, V, i dr.
Izdano: (2010)

Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
od: Ganusov, V, i dr.
Izdano: (2011)

The Role of T Cell Immunity in the Control of HIV Infection
od: Goonetilleke, N, i dr.
Izdano: (2010)

Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.
od: Fischer, W, i dr.
Izdano: (2010)

OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection
od: Hahn B, i dr.
Izdano: (2009-10-01)

Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.
od: Song, H, i dr.
Izdano: (2014)

Ontogeny of CD8+T Cells in Acute HIV-1 that Inhibit Autologous and Heterologous Transmitted/Founder (T/F) Viruses
od: Freel, SA, i dr.
Izdano: (2011)

Resistance of transmitted founder HIV-1 to IFITM-mediated restriction
od: Foster, T, i dr.
Izdano: (2016)

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
od: Jesus F. Salazar-Gonzalez, i dr.
Izdano: (2016-07-01)

Vaccine-elicited systemic and mucosal humoral responses of lactating rhesus monkeys vaccinated with the transmitted/founder HIV Envelope 1086C
od: Fouda G, i dr.
Izdano: (2012-09-01)

The immune response during acute HIV-1 infection: clues for vaccine development.
od: Mcmichael, A, i dr.
Izdano: (2010)

P20-17. Evolution of multiple transmitted viruses during the early stage of HIV-1 infection
od: McMichael A, i dr.
Izdano: (2009-10-01)

T Cell Escape in Subjects with Acute HIV-1 Infection
od: Liu, M, i dr.
Izdano: (2008)

The role of early T-cell responses in subjects with acute HIV-1 infection
od: Liu, M, i dr.
Izdano: (2009)

Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
od: Freel, SA, i dr.
Izdano: (2012)

Phenotypic properties of transmitted founder HIV-1.
od: Parrish, N, i dr.
Izdano: (2013)

P09-21 LB. Deep sequencing of HIV-1 from acute infection: low initial diversity, and rapid but variable CTL escape
od: Haynes B, i dr.
Izdano: (2009-10-01)

HIV-host interactions: implications for vaccine design
od: Haynes, B, i dr.
Izdano: (2016)

Residual Viremia in Treated HIV+ Individuals.
od: Jessica M Conway, i dr.
Izdano: (2016-01-01)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction
od: Borrow, P, i dr.
Izdano: (2019)

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.
od: Ferrari, G, i dr.
Izdano: (2011)

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
od: Borrow, P, i dr.
Izdano: (1994)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
od: Nina Hertoghs, i dr.
Izdano: (2019-01-01)

Phagocytic uptake of transmitted/founder virus-infected CD4+T cells enhances macrophage infection
od: Duncan, C, i dr.
Izdano: (2012)

Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.
od: Will Fischer, i dr.
Izdano: (2010-08-01)

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
od: Mark B. Stoddard, i dr.
Izdano: (2015-05-01)

Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.
od: Riou, C, i dr.
Izdano: (2012)

Novel SHIVs encoding transmitted/founder Envs for latency and cure research
od: A. Bauer, i dr.
Izdano: (2019-12-01)

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
od: Neeti Ananthaswamy, i dr.
Izdano: (2019-02-01)

Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection
od: Hongshuo Song, i dr.
Izdano: (2018-05-01)

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.
od: Hui Li, i dr.
Izdano: (2010-05-01)

Implications of viral transmitted/founder (T/F) dynamics on vaccine development
od: Alexander I. Mosa
Izdano: (2021-07-01)

Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing.
od: Salazar-Gonzalez, J, i dr.
Izdano: (2011)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
od: Fouda GG, i dr.
Izdano: (2012-09-01)

Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
od: Nicholas F Parrish, i dr.
Izdano: (2012-01-01)

A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity.
od: Mohammed Asmal, i dr.
Izdano: (2011-01-01)

Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006–2011)
od: Sheila N. Balinda, i dr.
Izdano: (2022-02-01)

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes.
od: Sean P O'Brien, i dr.
Izdano: (2019-04-01)

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
od: Amit Kumar, i dr.
Izdano: (2018-04-01)

Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
od: Fenton-May, A, i dr.
Izdano: (2013)